Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1957 1
1959 1
1962 1
1965 1
1969 1
1970 1
1975 1
1976 1
1978 1
1983 1
1987 1
1989 2
1994 1
1996 3
2000 3
2004 2
2005 1
2006 1
2007 1
2009 1
2010 3
2011 2
2014 1
2016 1
2017 1
2018 2
2019 1
2021 4
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for telecast
Search for telicast instead (1 results)
Telecast of operation.
LADIKA OA. LADIKA OA. Hosp Prog. 1957 Nov;38(11):98. Hosp Prog. 1957. PMID: 13474723 No abstract available.
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST.
Srirajaskanthan R, Pavel M, Kulke M, Clement D, Houchard A, Keeber L, Weickert MO. Srirajaskanthan R, et al. Clin Ther. 2021 Oct;43(10):1779-1785. doi: 10.1016/j.clinthera.2021.08.014. Epub 2021 Sep 28. Clin Ther. 2021. PMID: 34598813 Free article. Clinical Trial.
In this follow-up analysis, using pooled data from the 36-week open-label extensions of the TELESTAR (NCT01677910) and TELECAST (NCT02063659) phase III trials, we demonstrate that improvements in weight and nutritional parameters were sustained or further improved in patie …
In this follow-up analysis, using pooled data from the 36-week open-label extensions of the TELESTAR (NCT01677910) and TELECAST (NCT0 …
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.
Pavel M, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, Anthony LB, Kunz PL, Hörsch D, Weickert MO, Lapuerta P, Jiang W, Kassler-Taub K, Wason S, Fleming R, Fleming D, Garcia-Carbonero R. Pavel M, et al. Endocr Relat Cancer. 2018 Mar;25(3):309-322. doi: 10.1530/ERC-17-0455. Epub 2018 Jan 12. Endocr Relat Cancer. 2018. PMID: 29330194 Free PMC article. Clinical Trial.
Telotristat ethyl, a tryptophan hydroxylase inhibitor, was efficacious and well tolerated in the phase 3 TELESTAR study in patients with carcinoid syndrome (CS) experiencing 4 bowel movements per day (BMs/day) while on somatostatin analogs (SSAs). TELECAST, a phase 3 compa …
Telotristat ethyl, a tryptophan hydroxylase inhibitor, was efficacious and well tolerated in the phase 3 TELESTAR study in patients with car …
Telecast of a cholecystectomy.
Harbison SP, Watson WG, Jackson FC, Drapanas T. Harbison SP, et al. Postgrad Med. 1969 Oct;46(4):131-6. doi: 10.1080/00325481.1969.11697272. Postgrad Med. 1969. PMID: 5353748 No abstract available.
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome.
Dillon JS, Kulke MH, Hörsch D, Anthony LB, Warner RRP, Bergsland E, Welin S, O'Dorisio TM, Kunz PL, McKee C, Lapuerta P, Banks P, Pavel M. Dillon JS, et al. J Gastrointest Cancer. 2021 Mar;52(1):212-221. doi: 10.1007/s12029-020-00375-2. J Gastrointest Cancer. 2021. PMID: 32146619 Free PMC article. Clinical Trial.
BACKGROUND: Telotristat ethyl is approved to treat carcinoid syndrome diarrhea in combination with somatostatin analogs. In TELESTAR and TELECAST phase III studies, patients with carcinoid syndrome received telotristat ethyl 250 or 500 mg 3 times per day (tid) or placebo t …
BACKGROUND: Telotristat ethyl is approved to treat carcinoid syndrome diarrhea in combination with somatostatin analogs. In TELESTAR and …
Hypertension treatment guidelines.
Moser M, Papademetriou V, Pickering TG, Sica DA. Moser M, et al. J Clin Hypertens (Greenwich). 2004 Aug;6(8):452-7. doi: 10.1111/j.1524-6175.2004.03745.x. J Clin Hypertens (Greenwich). 2004. PMID: 15308884 Free PMC article.
In May 2004, a symposium updating the management of hypertension was held in Washington, DC. This was telecast to more than 200 medical facilities throughout the United States. ...
In May 2004, a symposium updating the management of hypertension was held in Washington, DC. This was telecast to more than 200 medic …
The mental health consequences on children of the war in Ukraine: A commentary.
Elvevåg B, DeLisi LE. Elvevåg B, et al. Psychiatry Res. 2022 Nov;317:114798. doi: 10.1016/j.psychres.2022.114798. Epub 2022 Aug 18. Psychiatry Res. 2022. PMID: 36057188
The news from Ukraine is currently full of heart-wrenching stories accompanied by graphic images of civilian casualties and massacres that are telecast world-wide on a daily basis. It is hard to fathom the magnitude of the devastation and disruption to regular lives and ev …
The news from Ukraine is currently full of heart-wrenching stories accompanied by graphic images of civilian casualties and massacres that a …
Bottom-up learning of explicit knowledge using a Bayesian algorithm and a new Hebbian learning rule.
Hélie S, Proulx R, Lefebvre B. Hélie S, et al. Neural Netw. 2011 Apr;24(3):219-32. doi: 10.1016/j.neunet.2010.12.002. Epub 2010 Dec 16. Neural Netw. 2011. PMID: 21239141 Review.
The new model is called TEnsor LEarning of CAusal STructure (TELECAST). In TELECAST, implicit processing is modeled using an unsupervised connectionist network (the Joint Probability EXtractor: JPEX) while explicit (causal) knowledge is implemented using a Bayesian …
The new model is called TEnsor LEarning of CAusal STructure (TELECAST). In TELECAST, implicit processing is modeled using an u …
Student telecast teaching in otorhinolaryngology.
Hung T, Vlantis AC, Tong MC, van Hasselt CA. Hung T, et al. Med Educ. 2006 Nov;40(11):1136-7. doi: 10.1111/j.1365-2929.2006.02577.x. Med Educ. 2006. PMID: 17054638 No abstract available.
43 results